Since ancient times, one of the most common physical complaints of mankind are headaches [1] . Having various forms, headaches affect a large part of the population and lower the quality of life by causing discomfort, limits in professional life, and problems in daily relations [2, 3] .
Introduction
the medicines used were recorded for all patients. Aura or non-aura migraines were recorded for the migraine group.
Patients with a chronic disease (hypertension, diabetes, chronic liver/ kidney/pulmonary disease, severe anemia, hematologic disease, and so on), chronic migraine and chronic TTH patients, patients receiving prophylactic treatment, patients with ischemic risk factors, patients with an acute or chronic infectious condition, patients using antibiotics, patients with intracranial space-occupying lesions, patients with malignity, patients with a history of pregnancy, and patients who had received treatment in the past year for anemia or polycythemia were excluded from the study. None of the patients had a history of surgery in the past 6 months. Furthermore, patients who drank alcohol and smoked, received anticoagulant and antiinflammatory treatment, used systemic corticosteroids, and had systemic inflammatory disease were excluded from the study.
The severity of pain was assessed with the visual analog scale (VAS). For using VAS, patients are asked to rate the severity of their headaches on a 10 cm scale varying from zero (no pain) to 10 (the worst pain imaginable).
Plt measurement
For the study, blood samples were taken from arm veins in tubes containing ethylenediamine tetraacetic acid (EDTA) and stored at room temperature. Samples were studied within 2 hours. The Plt number was observed using a Siemens automated blood counter.
Statistical method
Statistical analyses were performed with IBM SPSS for Windows, Version 22.0. Numeric variables are summarized as mean ± standard deviation. Categorical variables are shown as numbers and percentages. Differences between groups with regard to categorical changes were studied with the chi-square test. Normality of numeric variables was examined using the Kolmogorov-Smirnov test, and the homogeneity of the variances was examined with the Levene test. Differences between groups with regard to numeric variables were examined using a t-test in separate groups. More than two independent intergroup differences were examined with one-way analysis of variance for numeric variables. If differences were determined, two-way comparisons were performed with Tukey's honest significant difference test. The relation between numeric variables is presented with Spearman's correlation coefficient. The intercept for MPV, Plt, and MPV/Plt ratio differentiating migraine and TTH groups was determined using receiver operating characteristic (ROC) curve analysis. The sensitivity and selectivity values for the best intercept are presented. Area under the ROC curve was calculated. The level of significance was taken as P < 0.05.
Findings
Eighty migraine patients, 80 TTH patients, and 80 healthy subjects are enrolled in the study. The average age of the migraine patients was 33.0 ± 7.9, and 57 were female (71.3%), while 23 were male (28.7%). There was no statistical difference with regard to age and gender between patients and healthy control groups (P < 0.05).
The average headache period for migraine patients was 4.4 ± 2.9 year, and the average starting age for headaches was 28.7 ± 6.4 years. Moreover, the average headache period for TTH patients was 5.3 ± 3.1 year. They experienced 6.1 ± 2.6 days of headache monthly on average, and this pain lasted for 20.6 ± 8.5 hours on average. The average VAS score for the migraine patients was 7.9 ± 0.9, and it was higher than that in TTH by a statistically significant level (P < 0.05).
The MPV was 10.84 ± 0.66 in migraine patients, 10.16 ± 0.59 in the TTH group, and 9.99 ± 0.69 in the healthy control group. When MPV, Plt number, and MPV/Plt ratio were compared between patient and healthy control groups, the migraine group was determined to be statistically different (P < 0.05). There was no statistical difference between TTH and control groups (Tab. I). The MPV/ Plt ratio was 0.046 ± 0.008 in migraine patients, 0.037 ± 0.009 in patients with TTH, and 0.036 ± 0.009 in the healthy control group (Fig. 1) . The cutoff value of MPV/Plt ratio for differentiating migraine and TTH was 0.037. The sensitivity of this value was 92.5%, while specificity was 55% (Tab. II).
While 65 of the migraine patients (81.25%) had migraine without aura, 15 (18.75%) patients had migraine with aura. When MPV and MPV/Plt ratio were compared among patients who suffered from migraine with or without aura, there was no statistically significant difference (P > 0.05). MPV and Plt number were correlated with the headache period, starting age for headache, headache frequency, and severity of pain in the migraine patient group, and there was no statistically significant correlation (Tab. III). higher in the Plts of migraine patients in the headache-free period compared to the same in the healthy control group, and therefore, they suggested that Plt behavior may have a role in recurring migraine attacks and in the start of attacks since it is different in migraine patients relative to that in healthy people [22] . We have determined in our study that MPV and MPV/Plt ratio increase in a statistically significant manner in migraine patients in the period between attacks.
Table I. Mean platelet volume (MPV), platelet (Plt) number, and MPV/Plt ratio in migraine, tension-type headache (TTH), and healthy control groups
We have determined that this increase is independent of the starting age, period, and severity of the disease. Furthermore, this increase was of the same level in migraine patients with or without aura.
We think that this also supports the hypothesis that there is a Plt dysfunction in the pathophysiology of migraine.
In the hypothesis suggested for the pathophysiology of TTH, it is indicated that there is pain modulation with nociceptive stimulations from pericranial myofascial tissues causing sensitization at the upper cervical spinal dorsal root trigeminal core level and secondarily the sensitization of the supraspinal structures such as the thalamus or somatosensorial cortex [23] . In the study of Bendtsen et al., performed on TTH patients, in vivo interstitial concentrations of inflammatory mediators and metabolites were determined to be normal [24] . In our study, we determined that MPV and MPV/Plt ratio have similar levels in the healthy population. We have used these ratios in the differential diagnosis of migraine-type headaches, which are often confused with one another.
The limitations of our study are that 1) MPV is a biomarker easily affected by the preanalytical process after sampling, 2) tubes containing EDTA in which the samples are stored may alter Plt type and increase MPV, 3) although the samples are studied within 2 hours after sampling, MPV may change proportionally with time. Consequently, MPV is an important sign of Plt activation, which has an important role in the pathophysiology of the atherothrombotic process. Although MPV correlation has been examined in migraine patients before, its relation in the differentiation of TTH has never been studied. We have demonstrated that most commonly confused primary headache types may be differentiated by using MPV and MPV/Plt ratio, and therefore, the disability caused by migraine and unsuitable, unnecessary, and long-term drug therapies may be prevented for patients. Our results support our diagnosis.
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